Hero Image
Advertisement

Key Dates

  • ACC member registration opens.
  • General early bird registration opens.

Late-Breaking Clinical Trials

The American College of Cardiology is now accepting late-breaking clinical trial submissions for presentation at ACC.27-WCC. Accepted trial presenters will have the chance to present on cardiology's main stage, where they will help shape the future of cardiovascular care by sharing their research with the global cardiovascular community.

ACC.27-WCC is where groundbreaking discoveries, real-world cases and innovative ideas converge to shape the future of cardiovascular medicine. Attendees will have the opportunity to engage in dynamic discussions on ground-breaking research during seven LBCT sessions, five featured clinical research sessions, and two investigative horizons sessions. Be among the first to hear the data that will define tomorrow's practice!

Submit Late-Breaking Clinical Trials

Submission Dates: -

Late-breaking clinical trials can be submitted in the following categories:

  • Phase 2 or Phase 3 Multicenter Randomized Controlled Trial
  • Single-Center RCT or Phase 1 Multicenter Randomized Controlled Trial
  • Technology Advances or Novel Human Therapeutics
  • Multicenter Observational Study or Registry
  • Secondary Analysis of Major Clinical Trial

Accepted submissions will be presented in person during one of seven LBCT sessions in the Main Tent in Houston and streamed live on the ACC.27-WCC virtual platform. No video/virtual presentation option will be available.

Four LBCT sessions will be co-sponsored by the Journal of the American College of Cardiology (JACC), the Journal of the American Medical Association (JAMA), the New England Journal of Medicine (NEJM) and The Lancet. Each accepted submission will be considered for JACC Rapid Review and publication in JACC, JAMA, NEJM and The Lancet. In addition, each LBCT presentation is featured in an embargoed press conference before the session.

Are Your Disclosures Up To Date?

All submitting LCBT authors must have updated disclosures before submitting research.